Dexmedetomidine HCl

✨ ‌Dexmedetomidine Hydrochloride (CAS 145108-58-3) | Pharmaceutical-Grade Sedative Agent‌ ✨

🧪 ‌Product Overview‌

‌Dexmedetomidine Hydrochloride‌ (CAS 145108-58-3) is a highly selective ‌α2-adrenoceptor agonist‌ with potent sedative and analgesic properties. This white to off-white crystalline powder (≥99% purity, HPLC) is widely used in critical care and perioperative settings to reduce anxiety and pain while maintaining patient responsiveness. Its molecular formula is ‌C₁₃H₁₇ClN₂‌, with a molecular weight of ‌236.74‌.

‌Primary Functions‌:

• Induces sedation without respiratory depression.

• Reduces opioid requirements during surgery.

• Enhances hemodynamic stability in ICU patients.

‌Target Industries‌: Pharmaceuticals, hospital care, anesthesia management.

⭐ ‌Key Advantages‌

🏭 ‌Applications‌

• ‌Intensive Care‌

  : Sedation for mechanically ventilated patients.

• ‌Surgical Anesthesia‌

  : Adjunct to general or regional anesthesia.

• ‌Diagnostic Procedures‌

  : Non-invasive sedation (e.g., MRI, CT scans).

📊 ‌Quality Assurance‌

• ‌Testing Protocols‌

  : NMR, HPLC, mass spectrometry, and residual solvent analysis.

• ‌Stability‌

  : Long-term storage at 

  ‌2-8°C‌

   in sealed containers.

• ‌Regulatory Alignment‌

  : Complies with ICH Q7 and GMP guidelines.

📈 ‌Market Insights‌

The global sedation drugs market is projected to reach ‌$6.2 billion by 2030‌, driven by increasing surgical volumes and ICU admissions. Dexmedetomidine demand is rising at ‌7.1% CAGR‌, particularly in Asia-Pacific regions due to expanding healthcare infrastructure.